Molecular Simulations and Drug Discovery of Adenosine Receptors.
Jinan WangApurba BhattaraiHung N DoSana AkhterYinglong MiaoPublished in: Molecules (Basel, Switzerland) (2022)
G protein-coupled receptors (GPCRs) represent the largest family of human membrane proteins. Four subtypes of adenosine receptors (ARs), the A 1 AR, A 2A AR, A 2B AR and A 3 AR, each with a unique pharmacological profile and distribution within the tissues in the human body, mediate many physiological functions and serve as critical drug targets for treating numerous human diseases including cancer, neuropathic pain, cardiac ischemia, stroke and diabetes. The A 1 AR and A 3 AR preferentially couple to the G i/o proteins, while the A 2A AR and A 2B AR prefer coupling to the G s proteins. Adenosine receptors were the first subclass of GPCRs that had experimental structures determined in complex with distinct G proteins. Here, we will review recent studies in molecular simulations and computer-aided drug discovery of the adenosine receptors and also highlight their future research opportunities.
Keyphrases
- drug discovery
- endothelial cells
- neuropathic pain
- induced pluripotent stem cells
- gene expression
- pluripotent stem cells
- type diabetes
- spinal cord injury
- cardiovascular disease
- squamous cell carcinoma
- heart failure
- single molecule
- young adults
- papillary thyroid
- mass spectrometry
- adipose tissue
- room temperature
- insulin resistance
- subarachnoid hemorrhage
- ionic liquid
- weight loss
- electronic health record
- monte carlo
- cerebral ischemia